Orchid Bio-Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 01-11-2024
- Paid Up Capital ₹ 15.00 Cr
as on 01-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Orchid Bio-Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Orchid Bio-Pharma Limited India are Kapil Dayya as COMPANY SECRETARY and Sunil Gupta as Cfo. Ram Agarwal, Manish Dhanuka, and Mridul Dhanuka serve as directors at the Company.
- CIN/LLPIN
U24230TN2022PLC150784
- Company No.
150784
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2022
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Orchid Bio-Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kapil Dayya | Company Secretary | 05-Sep-2024 | Current |
Sunil Gupta  | CFO | 17-May-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mridul Dhanuka | Director | 24-Mar-2022 | Current |
| Ram Agarwal | Director | 24-Mar-2022 | Current |
| Manish Dhanuka | Director | 24-Mar-2022 | Current |
Financial Performance of Orchid Bio-Pharma.
Orchid Bio-Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orchid Bio-Pharma?
In 2023, Orchid Bio-Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Dhanuka Laboratories LimitedActive 31 years 10 monthsManish Dhanuka and Mridul Dhanuka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orchid Bio-Pharma?
Unlock and access historical data on people associated with Orchid Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orchid Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Bio-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
